Skip to content
Disclosery

Quadrature Capital Ltd: BIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Quadrature Capital Ltd on BIO, newest first. How the timeline and the estimate are built.

Quadrature Capital Ltd held 7,053 BIO shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,053 shares
    Change vs previous 13F +7,053 shares

    0.02% of the 13F portfolio, value $2,070,831.

    13F-HR 0001651424-26-000010 filed by Quadrature Capital Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -1,064 shares

    13F-HR 0001651424-25-000010 filed by Quadrature Capital Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-03-31
    13F 1,064 shares
    Change vs previous 13F -736 shares

    0.01% of the 13F portfolio, value $259,169.

    13F-HR 0001651424-25-000006 filed by Quadrature Capital Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 1,800 shares
    Change vs previous 13F -4,234 shares

    0.01% of the 13F portfolio, value $591,750.

    13F-HR 0001651424-25-000002 filed by Quadrature Capital Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 6,034 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $2,020,787.

    13F-HR 0001651424-24-000005 filed by Quadrature Capital Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).